GEORGETOWN SCHOOL OF MEDICINE FACTS
School of Medicine
Georgetown's School of Medicine provides a unique and comprehensive approach to medical education, always with an eye to the Jesuit ideal of cura personalis, or "care of the whole person," and with a curriculum that encourages students to give back to their communities, be they local, national, international, or global. As one of the most selective medical schools in the country, the School of Medicine is consistently ranked in US News and World Report's top 50 graduate programs at research universities. In 2004, the School of Medicine opened its Integrated Learning Center, which supports the School of Medicine's emphasis on a patient centered, competence-based curriculum and provides the latest methods of clinical teaching and evaluation. Georgetown medical students consistently match into top medical schools around the country for their residency programs.
Faculty: 1,470 faculty (746 full-time faculty; 724 part-time faculty)
Students: 756 medical students (M.D. candidates)
Tuition: $39,957 (2007-2008)
Financial aid: In 2006-07, 85 percent of Georgetown medical students received financial aid.
Admissions: For its incoming class of 2007, Georgetown University School of Medicine received 10,642 applications for 190 slots. The average science GPA of incoming students was 3.62.
RESEARCH
Georgetown University Medical Center received $138 million in funding in FY07. Approximately 60 percent of the Medical Center's funding is from the National Institutes of Health (NIH), and 30 percent is from other government sources. The remainder is from foundations, industry and other sources.
The Department of Medicine’s overall research accomplishments include significant growth in areas of proposal submission (up 55% from 2005 to 2006 and up 78% from 2006 to 2007). Grant funding from the federal, private and industry sectors grew to $13.2 million in FY 2007, which represents a 35.6% increase from FY 2006. These accomplishments have enabled the Department to continue to be at the forefront by offering innovative research ideas that further the Department’s educational and clinical practice missions.
Each division within the Department is actively engaged in basic, clinical or community research and in training/mentoring students and faculty for independent research careers. Funding for these activities comes from the National Institutes of Health, other governmental agencies, foundations, industry, and other sources. Current research efforts in the Department include hypertension; role of oxidative stress in renal disease; sex differences in health, aging and disease; disorders of water metabolism; treatment of type 2 diabetes; thyroid cancer; clinical trials of new agents to treat HIV; pulmonary hypertension in connective tissue disease; molecular epidemiology of cancer; hemophlilia. Funded training programs provide support to promote independent research careers for junior faculty interested in basic, translational and clinical research.
Lombardi Comprehensive Cancer Center
An integral part of the Medical Center, the Lombardi Comprehensive Cancer Center seeks to improve the diagnosis, treatment, and prevention of cancer through cutting-edge basic, translational, and clinical research, patient care, community education and outreach, and the training of cancer specialists for the future. Founded in 1970, Lombardi is one of only 39 institutions in the nation designated by the National Cancer Institute (NCI) as a comprehensive cancer center, and is the only one in the Washington region.
The Lombardi Cancer Center’s accomplishments include: National Cancer Institute funding increases of 55% since the last competitive renewal (2002) to $36 million; total cancer research funding increases to nearly $100 million since 2002 (48% increase); endowment funds that have more than tripled; therapeutic cancer clinical trial accruals for 2007 that exceeded 200; approved plans for a $16 million clinical building improvement project to better serve our cancer patients; having a rank of sixth in the world for publications on breast cancer research.
Biomedical Graduate Research Organization
Home to more than 60 percent of Georgetown University's sponsored research funding, Georgetown's Biomedical Graduate Research Organization (BGRO) was created to foster cutting-edge interdisciplinary collaboration and to enhance our basic science and translational research capacity, especially in the areas of neurosciences, child health and human development, cardiovascular-kidney diseases, infectious diseases and in collaborative work with researchers and clinicians from Georgetown's Lombardi Comprehensive Cancer Center. In addition to promoting this lifesaving research, our focus on educational and academic excellence in the biomedical sciences is helping to create the next generation of researchers in the United States and around the world.
SENIOR LEADERSHIP
SEARCH PROCESS
All materials submitted by or on behalf of candidates and nominees will be considered in strict confidence by the Search Advisory Committee, chaired by Dr. David B. Nelson, Professor and Chair of the Department of Pediatrics. Persons amenable to being considered are asked to submit an electronic version (Microsoft Word preferred) of their curriculum vita/resume and an optional letter highlighting their administrative accomplishments and qualifications for the position. Materials should be submitted as soon as possible to:
Dr. Ilene H. Nagel
Consultant to the Search Committee
Russell Reynolds Associates
Leader, Higher Education Practice
Gumed-chair@russellreynolds.com
(805) 325-2040 (Pacific Coast Time)